12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Company News  |  Deals

HTG Molecular Diagnostics, The Centre of Excellence for the Prevention of Organ Failure deal

HTG received exclusive rights to commercialize gene expression blood tests from the not-for-profit for the prognosis of chronic obstructive pulmonary disease...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >